List of publications, COST BM1007

1. Harvima IT, Nilsson G. Stress, the neuroendocrine system and mast cells: current understanding of their role in psoriasis. Expert Rev Clin Immunol. 2012 Mar;8(3):235-4
2. Sabato V, Verweij MM, Bridts CH, Levi-Schaffer F, Gibbs BF, De Clerck LS, Schiavino D, Ebo DG. CD300a is expressed on human basophils and seems to inhibit IgE/FcεRI-dependent anaphylactic degranulation. Cytometry B Clin Cytom. 2012 May;82(3):132-138
3. Harvima IT, Nilsson G. Mast cells as regulators of skin inflammation and immunity. Acta Derm Venereol. 2011 Oct;91(6):644-50
4. Suttle MM, Nilsson G, Snellman E, Harvima IT. Experimentally induced psoriatic lesion associates with IL-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor. Clin Exp Immunol 2012 Sep;169(3):311-9
5. Halova I, Draberova L and Draber P (2012). Mast cell chemotaxis – Chemoattractants and signaling pathways. Front. Immun. 3:119.
6. Dráber P, Sulimenko V and Dráberová E (2012). Cytoskeleton in mast cell signaling. Front. Immun. 3:130.
7. Köberle M, Kaesler S, Kempf W, Wölbing F and Biedermann T (2012) Tetraspanins in mast cells. Front. Immun. 3:106
8. Gri G, Frossi B, D'Incà F, Danelli L, Betto E, Mion F, Sibilano R and Pucillo C. Mast cell: an emerging partner in immune interaction. Front. Immun. 3:120
9. Lorentz A, Baumann A, Vitte J, Blank U (2012). The SNARE machinery in mast cell secretion. Front. Immun. 3:143
10. Ekoff M, Lyberg K, Krajewska M, Arvidsson M, Rak S, Reed JC, Harvima I, Nilsson G. Anti-apoptotic BFL-1 is the major effector in activation-induced human mast cell survival. Plos One. 2012;7(6).
11. Gibbs BF, Sabato V, Bridts CH, Ebo DG, Ben-Zimra M, Levi-Schaffer F. (2012) Expressions and inhibitory functions of CD300a receptors on purified human basophils. Exp. Dermatol. 21(11):884-885. doi: 10.1111/exd.12018
12. Gibbs BF, Levi-Schaffer F. H4 receptors in mast cells and basophils: a new therapeutic target for allergy? Front Biosci. 2012. 17:430-437. (Review)
13. Freichel M, Almering J, Tsvilovskyy V. The role of TRP proteins in mast cells. Front. Immunol., 12 June 2012
14. Zierau O, Zenclussen AC, Jensen F. Role of female sex hormones, estradiol and progesterone, in mast cell behavior. Front. Immunol., 19 June 2012
15. Sanding H, Bulfone-Paus S. TLR signaling in mast cells: common and unique features. Front. Immunol., 04 July 2012
16. Migalovich-Sheikhet H, Friedman S, Mankuta D, Levi-Schaffer F. Novel identified receptors on mast cells. Front. Immunol., 02 August 2012
17. Blank U, Benhamou M. Deciphering new molecular mechanisms of mast cell activation. Frontiers in molecular innate immunity (online)
18. Woidacki K, Jensen F, Zenclussen AC. Mast cells as novel mediators of reproductive processes. Front. Immunol., 14 February 2013
19. Ilves T, Harvima IT. OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity. J Eur Acad Dermatol Venereol 2013 Feb;27(2):e197-205.
20. Vukman KV, Adams PN, Metz M, Maurer M, O’Neill S. Mast cell’s ability to drive TH1 immune responses. J Immunol 2013; 190:2873-2879;
21. Förster A, Falcone FH, Gibbs BF, Preussner LM, Fiebig BS, Altunok H, Seeger JM, Cerny-Reiterer S, Rabenhorst A, Papenfuss K, Valent P, Kashkar H, Hartmann K. Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophils. Leuk Lymphoma. 2013 Apr;54(4):835-42
22. Torres R, Herrerias A, Serra-Pagès M, Marco A, Plaza J, Costa-Farré C, Montoya M, Picado C, de Mora F. Locally administered prostaglandin E2 prevents aeroallergen-induced airway sensitization in mice through immunomodulatory mechanisms.Pharmacological Research. Volume 70, Issue 1, April 2013, 50–59
23. Beghdadi W, Madjene LC, Claver J, Peijler G, Beaudoin L, Lehuen A, Daugas E, Blank U. Murine mast cell chymase (mMCP4) protects against renal fibrosis in unilateral ureteral obstruction. Kidney Int March 20. Epub ahead of print
24. Blank U, Falcone FH, Nilsson G. The history of mast cell and basophil research – some lessons learnt from the last century. Allergy (under revision)
25. Yang W, Schmid E, Nurbaeva MK, Szteyn K, Leibrock C, Yan J, Schaller M, Gulbins E, Shumilina E, Lang F. Role of acid sphingomyelinase in the regulation of mast cell function. Clin Exp Allergy. 2013 Oct 28. doi: 10.1111/cea.12229. Epub ahead of print
26. Nullens S, Sabato V, Faber M, Leysen J, Bridts CH, de Clerck LS, Falcone FH, Maurer M, Ebo DG. Basophilic histamine content and release during venom immunotherapy: Insights by flow cytometry. Cytometry Part B – Clin. CY 2013; 84:173-8
27. Maurer, M., Bindslev-Jensen, C., Gimenez-Arnau, A., Godse, K., Grattan, C. E. M., Hide, M., Kaplan, A. P., Makris, M., Simons, F. E. R., Zhao, Z., Zuberbier, T., and Church, M. K.: Chronic idiopathic urticaria (CIU) is no longer idiopathic: time for an update! Br. J. Dermatol. 2013: 168; 455-456
28. Siebenhaar, F., Metz, M., and Maurer, M.: Mast cells protect from skin tumor development and limit tumor growth during cutaneous de novo carcinogenesis in a Kit-dependent mouse model. Exp. Dermatol. 2014: in press
29. Vukman, K. V., Adams, P., N., Dowling, D., Metz, M., Maurer, M., and O’Neill, S. M.: The effects of Fasciola hepatica tegumental antigens on mast cell function. Int. J. Parasitol. 2013: in press
30. Nelissen, S., Vangansewinkel, T., Geurts, N., Geboes, L., Lemmens, E., Vidal, P. M., Lemmens, S., Willems, L., Boato, F., Dooley, D., Pehl, D., Pejler, G., Maurer, M., Metz, M., and Hendrix, S.: Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4. Neurobiol. Dis. 2013: 62C; 260-272
31. Harvima, I. T., Levi-Schaffer, F., Draber, P., Friedman, S., Polakovicova, I., Gibbs, B. F., Blank, U., Nilsson, G., Maurer, M.: Molecular targets on mast cells and basophils for novel therapies. J. Allergy Clin. Immunol. 2014: in press
32. V Sabato, M Boita, S Shubber, CH Bridts, A Shibuya, LS De Clerck, FH Falcone, DG Ebo. Mechanism of phosphatidylserine inhibition of IgE/FcεRI-dependent anaphylactic human basophil degranulation via CD300a. J. Allergy Clin. Immunol. 2014 In press
33. Mizrahi, S., Gibbs, B.F., Karra, L., Ben-Zimra, M., Levi-Schaffer, F.: Siglec-7 is an inhibitory receptor on human mast cells and basophils. J. Allergy Clin. Immunol. 2014: in press
34. Rivellese F, Suurmond J, de Paulis A, Marone G, Huizinga TW, Toes RE. IgE and IL-33-mediated triggering of human basophils inhibits TLR4-induced monocyte activation. Eur J Immunol. 2014 Jul 28. doi: 10.1002/eji.201444731. [Epub ahead of print]
35. Rohit Salujaa, Maria E. Ketelaarb, Tomasz Hawro, Martin K. Church, Marcus Maurer, Martijn C. Nawijn. The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders. Molecular Immunology 63 (2015) 80–85
36. Vadym Sulimenko, Zuzana Hájková, Markéta Cernohorská, Tetyana Sulimenko, Vladimíra Sládková, Lubica Dráberová, Stanislav Vinopal, Eduarda Dráberová and Pavel Dráber. Microtubule Nucleation in Mouse Bone Marrow−Derived Mast Cells Is Regulated by the Concerted Action of GIT1/ βPIX Proteins and Calcium. J Immunol 2015; 194:4099-4111; Prepublished online 27 March 2015; doi: 10.4049/jimmunol.1402459
37. Zuzana Rubíková, Vadym Sulimenko, Tomáš Paulenda and Pavel Dráber. Mast Cell Activation and Microtubule Organization Are Modulated by Miltefosine Through Protein Kinase C Inhibition. Front Immunol. 2018 Jul 9;9:1563. doi: 10.3389/fimmu.2018.01563. eCollection 2018.

Last updated:


News & Events

EMBRN volume on mast cells and basophils and their functions is now in press in Immunological Reviews

Immunological Reviews just published a series of reports on mast cells, basophils and their role in health and disease (Immunological Reviews 2018; Vol 82, page 1-277).

Original and review papers on mast cells / basophils wanted!

Our colleagues Thomas Marichal, Nicolas Gaudenzio, Laurent Reber, and Philipp Starkl are putting together, as guest editors, a Special Issue on the regulation of type 2 immunity by mast cells and...


Report Final Conference of COST Action BM1007 (2011-2015)

Mast Cells and Basophils – Targets for Innovative Therapies

Final Report – COST ACTION BM1007 2nd Training School

Jerusalem, Israel, January 20-21, 2014

School of Pharmacy hosts International Training School funded by COST Action BM1007

The School of Pharmacy, University of Nottingham recently hosted an International Training School funded by the COST Action Biomedicine and Molecular Biosciences BM1007 "Mast Cells and Basophils -...

Our Partners